Learn More
OBJECTIVE To explore the changes of surface antigen and function of rituximab on dendritic cells derived from patients with Primary immune thrombocytopenia (ITP) to further understand the effective mechanism of immunotherapy. METHODS The peripheral blood mononuclear cells (PBMCs) were isolated from remission patients with ITP before and after low-dose(More)
  • 1